Tuesday, June 18

HONG KONG, Nov 14, 2022 – (ACN Newswire) – China Resources Pharmaceutical Group Limited (“CR Pharmaceutical” or the “Group”) (stock code: 3320) has announced that the Group will once again be included as a constituent stock of the MSCI China Index, which will become effective after the market close on 30 November 2022.The MSCI Indexes are key benchmarks for institutional investors investing in the global equity markets…
Read More

Comments are closed.